No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
GRI Bio Price Target Announced at $10.00/Share by HC Wainwright & Co.
Express News | GRI Bio, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating
GRI Bio to Participate in the Virtual Investor Closing Bell Series
Ascendiant Capital Maintains Buy on GRI Bio, Raises Price Target to $13
GRI Bio Analyst Ratings
GRI Bio Highlights GRI-0621's Potential To Reduce Inflammation And Hepatic Fibrosis In Idiopathic Pulmonary Fibrosis, With Positive Preclinical Data Presented At AFDD Summit And Phase 2 Topline Data Expected In Q2 2025
Unlock the Full List